February 20, 2018
Ritter Pharmaceuticals assigns specialist as it focuses on the first FDA-approved treatment for lactose intolerance
Ritter Pharmaceuticals will seek to do make sure its first pivotal Phase 3 clinical trial of RP-G28 for lactose intolerance…